Evidence map›Paper›PMID 35702592›Full record

ReviewNature reviews. Chemistry2022

The chemistry of snake venom and its medicinal potential.

Ana L Oliveira, Matilde F Viegas, Saulo L da Silva, Andreimar M Soares, Maria J Ramos, Pedro A Fernandes

Open access · bronzeAbstract readReview
In one paragraph

Review in Nature reviews. Chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 122 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
122citing papers in PubMed, 2 pooled it
44.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

122 citing papers in PubMed, 2 syntheses or guidelines pooled it, 257 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Biological Effects of Secretory Phospholipase ABulletin of experimental biology and medicine · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

62 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ana L OliveiraDepartment of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.ORCID 0000-0001-6594-6022
Matilde F ViegasDepartment of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.ORCID 0000-0002-4472-9691
Saulo L da SilvaDepartment of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.ORCID 0000-0002-7029-2016
Andreimar M SoaresBiotechnology Laboratory for Proteins and Bioactive Compounds from the Western Amazon, Oswaldo Cruz Foundation, National Institute of Epidemiology in the Western Amazon (INCT-EpiAmO), Porto Velho, Brazil.ORCID 0000-0003-1032-2188
Maria J RamosDepartment of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.ORCID 0000-0002-7554-8324
Pedro A FernandesDepartment of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Porto, Portugal.ORCID 0000-0003-2748-4722
Universidade do Porto · PTCentro Universitário São Lucas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fascination and fear of snakes dates back to time immemorial, with the first scientific treatise on snakebite envenoming, the Brooklyn Medical Papyrus, dating from ancient Egypt. Owing to their lethality, snakes have often been associated with images of perfidy, treachery and death. However, snakes did not always have such negative connotations. The curative capacity of venom has been known since antiquity, also making the snake a symbol of pharmacy and medicine. Today, there is renewed interest in pursuing snake-venom-based therapies. This Review focuses on the chemistry of snake venom and the potential for venom to be exploited for medicinal purposes in the development of drugs. The mixture of toxins that constitute snake venom is examined, focusing on the molecular structure, chemical reactivity and target recognition of the most bioactive toxins, from which bioactive drugs might be developed. The design and working mechanisms of snake-venom-derived drugs are illustrated, and the strategies by which toxins are transformed into therapeutics are analysed. Finally, the challenges in realizing the immense curative potential of snake venom are discussed, and chemical strategies by which a plethora of new drugs could be derived from snake venom are proposed.

Indexed as

BiochemistryDrug discovery

Identifiers

PMID35702592
PMCPMC9185726
OpenAlexW4281744888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.